Significant Ownership of ADAR1 Capital Management, LLC

Signature - Title
/s/ Daniel Schneeberger - Daniel Schneeberger, Manager
Location
Austin, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by ADAR1 Capital Management, LLC.

Notify me when ADAR1 Capital Management, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of ADAR1 Capital Management, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IKT Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value 9.9% $12,999,326 +$1,248,993 7,737,694 +11% ADAR1 Capital Management GP, LLC 30 Jun 2025
EQ Equillium, Inc. Common Stock, par value $0.0001 per share 9.9% $8,858,062 6,194,882 ADAR1 Capital Management GP, LLC 30 Sep 2025
IBIO iBio, Inc. Common Stock, par value $0.001 per share 9.9% $1,417,303 +$551,490 1,794,055 +64% ADAR1 Capital Management, LLC 30 Jun 2025
KPRX Kiora Pharmaceuticals, Inc. Common Stock, par value $0.01 per share 9.9% $1,029,805 365,179 ADAR1 Capital Management GP, LLC 30 Jun 2025
ACST Grace Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% 1,534,254 +2.1% ADAR1 Capital Management GP, LLC 30 Sep 2025
BIOA BioAge Labs, Inc. Common Stock, par value $0.00001 per share 5.4% $9,298,190 1,937,123 ADAR1 Capital Management, LLC 30 Jun 2025
KALA KALA BIO, Inc. Common Stock, par value $0.001 per share 4.9% $1,007,478 298,955 ADAR1 Capital Management, LLC 31 Dec 2024
ZURA ZURA BIO LIMITED Class A Ordinary Shares, par value $0.0001 per share 3.2% $2,326,521 2,077,251 ADAR1 Capital Management, LLC 31 Dec 2024
PRTA Prothena Corporation Public Limited Company Ordinary Shares, par value $0.01 per share 2.7% $14,338,396 -$18,601,691 1,469,098 -56% ADAR1 Capital Management, LLC 30 Sep 2025
CLRB Cellectar Biosciences, Inc. Common Stock, $0.00001 par value per share 0.1% 2,962 ADAR1 Capital Management, LLC 30 Jun 2025
KROS Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share 0% $0 -$85,258,156 0 -100% ADAR1 Capital Management, LLC 15 Oct 2025

Schedules 13D/G Reported by ADAR1 Capital Management, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.